Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066664
Status:
COMPLETED
Last Update Posted:
2012-03-15
First Post:
2003-08-06
Brief Title:
Serum Protein Patterns in Participants With Mycosis FungoidesCutaneous T-Cell Lymphoma Psoriasis or Normal Skin
Sponsor:
National Institutes of Health Clinical Center CC
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Characterization of Serum Proteomic Patterns in Neoplastic and Inflammatory Skin Disease
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE The presence of specific serum proteins may allow a doctor to determine if a patient has mycosis fungoidescutaneous T-cell lymphoma
PURPOSE This clinical trial is studying how well blood protein analysis detects mycosis fungoidescutaneous T-cell lymphoma
PURPOSE This clinical trial is studying how well blood protein analysis detects mycosis fungoidescutaneous T-cell lymphoma
Detailed Description:
OBJECTIVES
Determine whether computer-assisted higher-order analysis of participant low molecular weight serum proteins can detect distinctive proteomic patterns in participants with normal skin vs mycosis fungoidescutaneous T-cell lymphoma vs psoriasis
Determine whether these proteomic patterns can distinguish between various stages of cutaneous T-cell lymphoma
OUTLINE This is a pilot study
Participants complete a general and skin health questionnaire and undergo a whole-body skin examination Blood samples are taken and analyzed for low molecular weight serum proteins by mass spectroscopy
PROJECTED ACCRUAL A total of 141-423 participants 47-94 each of healthy volunteers psoriasis patients and T3 cutaneous T-cell lymphoma patients and 141 T1 T2 and T4 mycosis fungoides patients will be accrued for this study within 3 years
Determine whether computer-assisted higher-order analysis of participant low molecular weight serum proteins can detect distinctive proteomic patterns in participants with normal skin vs mycosis fungoidescutaneous T-cell lymphoma vs psoriasis
Determine whether these proteomic patterns can distinguish between various stages of cutaneous T-cell lymphoma
OUTLINE This is a pilot study
Participants complete a general and skin health questionnaire and undergo a whole-body skin examination Blood samples are taken and analyzed for low molecular weight serum proteins by mass spectroscopy
PROJECTED ACCRUAL A total of 141-423 participants 47-94 each of healthy volunteers psoriasis patients and T3 cutaneous T-cell lymphoma patients and 141 T1 T2 and T4 mycosis fungoides patients will be accrued for this study within 3 years
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CDR0000316453 | None | None | None |
| 03-C-0228 | None | None | None |